Want to see what other hedge funds are holding MCHP? Dana Inv Advsrs invested in 79,557 shares. The fund owned 223,350 shares of the semiconductor company's stock after purchasing an additional 9,173 shares during the quarter.
Microchip Technology Incorporated (MCHP) stock price escalated 0.10% to finalize at $89.02 throughout previous buying and selling session. The company has a debt-to-equity ratio of 0.95, a current ratio of 2.98 and a quick ratio of 2.33. The Beta factor, which is used riskiness of the security was 1.12. Northeast Consultants Inc holds 0.89% or 18,456 shares. Toronto Dominion Bank now owns 77,852 shares of the semiconductor company's stock valued at $6,007,000 after purchasing an additional 19,026 shares during the last quarter. The shares were sold at an average price of $84.18, for a total transaction of $177,535.62. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Shares for $349,938 were sold by LITTLE MITCHELL R on Thursday, February 22. Evercore Wealth Mgmt Ltd Liability Company owns 0.01% invested in Microchip Technology Incorporated (NASDAQ:MCHP) for 1,835 shares. The price target is the price an analyst believes the stock will achieve during their investment time horizon, which for most firms is 12 months. The stock of Microchip Technology Incorporated (NASDAQ:MCHP) earned "Neutral" rating by Goldman Sachs on Friday, November 4. KeyCorp raised shares of Microchip Technology to an "overweight" rating in a research report on Friday. Then this week, the Wall Street Journal reported the potential Microchip deal. Bank of America upgraded the shares of MCHP in report on Tuesday, November 8 to "Buy" rating.
Among 6 analysts covering Dillard's (NYSE:DDS), 1 have Buy rating, 3 Sell and 2 Hold.
We've taken a serious look at this stock from a fundamental perspective, but the tale of the tape may offer more hints about what lies under the surface. At current stock price levels, we have noted that MCHP's stock price is separated -10.33% from the 52 week high and 24.55% off of the 52 week low. Sun Life Financial Incorporated invested 0.04% in Microchip Technology Incorporated (NASDAQ:MCHP). The Coho Partners Ltd holds 1.59M shares with $143.08 million value, down from 1.68 million last quarter.
MSCC has the market capitalization of $7.40B and its EPS growth ratio for the past five years was 44.80%. The Price to Sales (P/S) of the company is 2.55, while P/B (Price to Book) stands at 1.6.
Microchip Technology (NASDAQ:MCHP) pays an annual dividend of $1.45 with a yield of 1.63% and an average dividend growth of 0.60% based on a 3 Year Average.
Usa Financial Portformulas Corp decreased its stake in Microchip Technology Inc (MCHP) by 42.11% based on its latest 2017Q3 regulatory filing with the SEC. The business had revenue of $994.10 million for the quarter, compared to analysts' expectations of $992.10 million. Bard Associate invested in 1.07% or 245,785 shares.
Based on now available information, Microchip said it anticipated achieving an estimated United States dollars 300 million in synergies within three years and that the transaction is expected to be immediately accretive to Microchip's non-GAAP earnings per share. Hudock Cap Gp Llc holds 43 shares or 0% of its portfolio. This is a positive change from Microchip Technology's previous quarterly dividend of $0.36.
On 5/9/2017 Microchip Technology announced a quarterly dividend of $0.36 1.83% with an ex dividend date of 5/19/2017 which will be payable on 6/6/2017. Microchip Technology's dividend payout ratio is now 39.94%. If you are accessing this article on another website, it was illegally copied and reposted in violation of US and worldwide trademark & copyright legislation. "(MCHP) Stake Raised by First Trust Advisors LP" was originally posted by registrarjournal.com and is owned by of registrarjournal.com. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of US and worldwide trademark and copyright legislation. It operates through two divisions, Human Pharmaceutical Products and Animal Health Products.